Sanket Koul

Stories by Sanket Koul

Why Are Child TB Cases Rising?

Why Are Child TB Cases Rising?

Rediff.com   17 Apr 2025

Children below the age of 15 years account for about 10 to 12 per cent of India's overall TB burden.

Unsold affordable units drop 19% in top 7 cities in Q1CY25, bucking slump

Unsold affordable units drop 19% in top 7 cities in Q1CY25, bucking slump

Rediff.com   15 Apr 2025

After the post-pandemic slump in demand, unsold inventory in the affordable housing segment in the top seven cities dropped by 19 per cent in the first quarter of the 2025 calendar year (Q1CY25), according to a report by real estate consultancy firm Anarock.

USTR flags hurdles in medical device exports to India

USTR flags hurdles in medical device exports to India

Rediff.com   2 Apr 2025

The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as key obstacles for US businesses.

Panel Flags CBSE's Dual Exam Plan

Panel Flags CBSE's Dual Exam Plan

Rediff.com   29 Mar 2025

In its draft policy released last month, the CBSE had proposed conducting Class 10 board exams twice in an academic year from 2026.

Latest trend in India's key realty markets

Latest trend in India's key realty markets

Rediff.com   18 Mar 2025

Capital value appreciation outpaced rental value growth in several key micro-markets between 2021 and 2024, with Noida Sector 150 in the National Capital Region (NCR) leading the pack with a 128 per cent rise in capital values compared to rental value growth of just 66 per cent, according to a report by property consulting firm Anarock.

Why India's medical device makers are moving to Vietnam, Malaysia

Why India's medical device makers are moving to Vietnam, Malaysia

Rediff.com   14 Mar 2025

A large number of medical device-manufacturing units have been forced to move to Vietnam and Malaysia due to delays, inconsistent timelines, and a lack of transparency in licensing processes, according to the Parliamentary Standing Committee on Health and Family Welfare.

After Delhi's sign-in, Bengal only state to hold out on Ayushman Bharat

After Delhi's sign-in, Bengal only state to hold out on Ayushman Bharat

Rediff.com   28 Feb 2025

According to a parliamentary response by the Union health ministry in 2023, around 654,000 families in Delhi are eligible to enrol under the scheme.

Private hospitals to boost cancer care, beds count

Private hospitals to boost cancer care, beds count

Rediff.com   27 Feb 2025

'Cancer incidence is projected to increase by 12.8 per cent by 2025 compared with 2020, necessitating more dedicated cancer treatment centres and specialised beds.'

'7,000 More MBBS Seats, 3,000 For PG'

'7,000 More MBBS Seats, 3,000 For PG'

Rediff.com   17 Feb 2025

India is trying to add 75,000 medical seats in five years as it also eyes to touch the WHO standard of one doctor for every 1,000 persons.

USAID Funding To India Declines Amid Trump's Freeze

USAID Funding To India Declines Amid Trump's Freeze

Rediff.com   13 Feb 2025

'If the Bill and Melinda Gates Foundation cuts funds, there could be more impact.'

Budget Prepares For Rise In Cancer Cases

Budget Prepares For Rise In Cancer Cases

Rediff.com   3 Feb 2025

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?

US WHO Exit Won't Impact India: Experts

US WHO Exit Won't Impact India: Experts

Rediff.com   22 Jan 2025

'Both international cooperation and self-reliance will now acquire new purpose.'

Fake medicines worth Rs 6.6 crore seized in Kolkata

Fake medicines worth Rs 6.6 crore seized in Kolkata

Rediff.com   1 Jan 2025

'Anti-cancer, anti-diabetic, and other drugs suspected to be spurious were seized from the raid carried out at the firm.'

Offers Pour In At IITs' Placement Season

Offers Pour In At IITs' Placement Season

Rediff.com   24 Dec 2024

Major recruiters, with double-digit offers at IIT campuses this year so far, include American Express, Barclays, BCG, Cars24, Deutsche Bank, Goldman Sachs, Google, Intel India, Meesho, Micron Technology, Microsoft, OLA, Oracle, Reliance, and Qualcomm.

618 Drugs 'Not Of Standard Quality'

618 Drugs 'Not Of Standard Quality'

Rediff.com   9 Dec 2024

Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid. Medications using these combinations are commonly used to treat fever, mild migraine, period and muscle pain.

Half of India Faces Glucose Imbalance

Half of India Faces Glucose Imbalance

Rediff.com   5 Dec 2024

'Obesity, especially central obesity and increased visceral fat due to physical inactivity, along with the consumption of high-calorie, high-fat, and high-sugar diets, are major contributing factors.'

AQI Spike Triggers Health Crisis

AQI Spike Triggers Health Crisis

Rediff.com   20 Nov 2024

'Many of these patients arrive at emergency departments in distress, struggling to breathe and requiring immediate medical intervention.'

What's Driving Surge in Breast Cancer?

What's Driving Surge in Breast Cancer?

Rediff.com   1 Nov 2024

Late-stage diagnosis is a major issue, with over 75 per cent of cases being detected at advanced stages (50 per cent at Stage 3 and 25 per cent at Stage 4). This significantly reduces survival rates.

Mpox Puts Health System On High Alert

Mpox Puts Health System On High Alert

Rediff.com   17 Aug 2024

Strict screening protocols are to be implemented for passengers arriving from central African countries affected by the outbreak.

Mankind Pharma to lead in Indian women's health market after BSV deal

Mankind Pharma to lead in Indian women's health market after BSV deal

Rediff.com   29 Jul 2024

New Delhi-based pharmaceutical major Mankind Pharma is poised to take pole position in women's health portfolio in the India Pharma Market (IPM) after completing the Rs 13,630 crore deal to acquire Bharat Serums and Vaccines (BSV), senior company officials said. The deal potentially opens doors for Mankind Pharma to the overseas markets, which currently draws 92 per cent of its revenues from India. The combined entity will draw around 13 per cent revenues from the international market, with the remaining coming from the domestic market.